Global Anti-androgen Drugs Market Growth 2026-2032
The global Anti-androgen Drugs market size is predicted to grow from US$ 7432 million in 2025 to US$ 17786 million in 2032; it is expected to grow at a CAGR of 13.0% from 2026 to 2032.
Anti-androgen drugs are a class of therapeutics that inhibit androgen production, block androgen receptor (AR) signaling, or interfere with downstream androgen pathways, primarily used to treat androgen-dependent diseases, with prostate cancer as the core indication, while also covering conditions such as polycystic ovary syndrome (PCOS), hirsutism, and gender-affirming hormone therapy; the category includes non-steroidal AR inhibitors (e.g., Enzalutamide, Apalutamide, Darolutamide), steroidal anti-androgens (e.g., Cyproterone Acetate), and androgen biosynthesis inhibitors (e.g., Abiraterone Acetate), forming a comprehensive market characterized by mechanistic diversity and indication-driven demand.
United States market for Anti-androgen Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Anti-androgen Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Anti-androgen Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Anti-androgen Drugs players cover Astellas, Pfizer, Johnson & Johnson, Bayer AG, Orion, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Anti-androgen Drugs Industry Forecast? looks at past sales and reviews total world Anti-androgen Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Anti-androgen Drugs sales for 2026 through 2032. With Anti-androgen Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-androgen Drugs industry.
This Insight Report provides a comprehensive analysis of the global Anti-androgen Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-androgen Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Anti-androgen Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-androgen Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-androgen Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-androgen Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Anti-androgen Drugs market?
What factors are driving Anti-androgen Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anti-androgen Drugs market opportunities vary by end market size?
How does Anti-androgen Drugs break out by Type, by Application?
Anti-androgen drugs are a class of therapeutics that inhibit androgen production, block androgen receptor (AR) signaling, or interfere with downstream androgen pathways, primarily used to treat androgen-dependent diseases, with prostate cancer as the core indication, while also covering conditions such as polycystic ovary syndrome (PCOS), hirsutism, and gender-affirming hormone therapy; the category includes non-steroidal AR inhibitors (e.g., Enzalutamide, Apalutamide, Darolutamide), steroidal anti-androgens (e.g., Cyproterone Acetate), and androgen biosynthesis inhibitors (e.g., Abiraterone Acetate), forming a comprehensive market characterized by mechanistic diversity and indication-driven demand.
United States market for Anti-androgen Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Anti-androgen Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Anti-androgen Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Anti-androgen Drugs players cover Astellas, Pfizer, Johnson & Johnson, Bayer AG, Orion, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Anti-androgen Drugs Industry Forecast? looks at past sales and reviews total world Anti-androgen Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Anti-androgen Drugs sales for 2026 through 2032. With Anti-androgen Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-androgen Drugs industry.
This Insight Report provides a comprehensive analysis of the global Anti-androgen Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-androgen Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Anti-androgen Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-androgen Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-androgen Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-androgen Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- NSARIs
- SARIs
- ASIs
- 1st Gen
- 2nd Gen
- nmCRPC
- mCRPC
- mHSPC
- Special Endocrine / Female
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Astellas
- Pfizer
- Johnson & Johnson
- Bayer AG
- Orion
- Teva Pharmaceutical
- Sun Pharmaceutical
- Dr. Reddy's Laboratories
- Cipla
- Hengrui Pharmaceuticals
- Lonza Group
- WuXi AppTec
- Asymchem Laboratories
- Catalent
What is the 10-year outlook for the global Anti-androgen Drugs market?
What factors are driving Anti-androgen Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anti-androgen Drugs market opportunities vary by end market size?
How does Anti-androgen Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-androgen Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Anti-androgen Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Anti-androgen Drugs by Country/Region, 2021, 2025 & 2032
2.2 Anti-androgen Drugs Segment by Type
2.2.1 NSARIs
2.2.2 SARIs
2.2.3 ASIs
2.2.4 Anti-androgen Drugs Sales by Type
2.2.4.1 Global Anti-androgen Drugs Sales Market Share by Type (2021-2026)
2.2.4.2 Global Anti-androgen Drugs Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Anti-androgen Drugs Sale Price by Type (2021-2026)
2.3 Anti-androgen Drugs Segment by Generation
2.3.1 1st Gen
2.3.2 2nd Gen
2.3.3 Anti-androgen Drugs Sales by Generation
2.3.3.1 Global Anti-androgen Drugs Sales Market Share by Generation (2021-2026)
2.3.3.2 Global Anti-androgen Drugs Revenue and Market Share by Generation (2021-2026)
2.3.3.3 Global Anti-androgen Drugs Sale Price by Generation (2021-2026)
2.4 Anti-androgen Drugs Segment by Application
2.4.1 nmCRPC
2.4.2 mCRPC
2.4.3 mHSPC
2.4.4 Special Endocrine / Female
2.4.5 Anti-androgen Drugs Sales by Application
2.4.5.1 Global Anti-androgen Drugs Sale Market Share by Application (2021-2026)
2.4.5.2 Global Anti-androgen Drugs Revenue and Market Share by Application (2021-2026)
2.4.5.3 Global Anti-androgen Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Anti-androgen Drugs Breakdown Data by Company
3.1.1 Global Anti-androgen Drugs Annual Sales by Company (2021-2026)
3.1.2 Global Anti-androgen Drugs Sales Market Share by Company (2021-2026)
3.2 Global Anti-androgen Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global Anti-androgen Drugs Revenue by Company (2021-2026)
3.2.2 Global Anti-androgen Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Anti-androgen Drugs Sale Price by Company
3.4 Key Manufacturers Anti-androgen Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-androgen Drugs Product Location Distribution
3.4.2 Players Anti-androgen Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTI-ANDROGEN DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Anti-androgen Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global Anti-androgen Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Anti-androgen Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Anti-androgen Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global Anti-androgen Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global Anti-androgen Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Anti-androgen Drugs Sales Growth
4.4 APAC Anti-androgen Drugs Sales Growth
4.5 Europe Anti-androgen Drugs Sales Growth
4.6 Middle East & Africa Anti-androgen Drugs Sales Growth
5 AMERICAS
5.1 Americas Anti-androgen Drugs Sales by Country
5.1.1 Americas Anti-androgen Drugs Sales by Country (2021-2026)
5.1.2 Americas Anti-androgen Drugs Revenue by Country (2021-2026)
5.2 Americas Anti-androgen Drugs Sales by Type (2021-2026)
5.3 Americas Anti-androgen Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-androgen Drugs Sales by Region
6.1.1 APAC Anti-androgen Drugs Sales by Region (2021-2026)
6.1.2 APAC Anti-androgen Drugs Revenue by Region (2021-2026)
6.2 APAC Anti-androgen Drugs Sales by Type (2021-2026)
6.3 APAC Anti-androgen Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Anti-androgen Drugs by Country
7.1.1 Europe Anti-androgen Drugs Sales by Country (2021-2026)
7.1.2 Europe Anti-androgen Drugs Revenue by Country (2021-2026)
7.2 Europe Anti-androgen Drugs Sales by Type (2021-2026)
7.3 Europe Anti-androgen Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-androgen Drugs by Country
8.1.1 Middle East & Africa Anti-androgen Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa Anti-androgen Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Anti-androgen Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Anti-androgen Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-androgen Drugs
10.3 Manufacturing Process Analysis of Anti-androgen Drugs
10.4 Industry Chain Structure of Anti-androgen Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-androgen Drugs Distributors
11.3 Anti-androgen Drugs Customer
12 WORLD FORECAST REVIEW FOR ANTI-ANDROGEN DRUGS BY GEOGRAPHIC REGION
12.1 Global Anti-androgen Drugs Market Size Forecast by Region
12.1.1 Global Anti-androgen Drugs Forecast by Region (2027-2032)
12.1.2 Global Anti-androgen Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Anti-androgen Drugs Forecast by Type (2027-2032)
12.7 Global Anti-androgen Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Astellas
13.1.1 Astellas Company Information
13.1.2 Astellas Anti-androgen Drugs Product Portfolios and Specifications
13.1.3 Astellas Anti-androgen Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Astellas Main Business Overview
13.1.5 Astellas Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Anti-androgen Drugs Product Portfolios and Specifications
13.2.3 Pfizer Anti-androgen Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Information
13.3.2 Johnson & Johnson Anti-androgen Drugs Product Portfolios and Specifications
13.3.3 Johnson & Johnson Anti-androgen Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Johnson & Johnson Main Business Overview
13.3.5 Johnson & Johnson Latest Developments
13.4 Bayer AG
13.4.1 Bayer AG Company Information
13.4.2 Bayer AG Anti-androgen Drugs Product Portfolios and Specifications
13.4.3 Bayer AG Anti-androgen Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Bayer AG Main Business Overview
13.4.5 Bayer AG Latest Developments
13.5 Orion
13.5.1 Orion Company Information
13.5.2 Orion Anti-androgen Drugs Product Portfolios and Specifications
13.5.3 Orion Anti-androgen Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Orion Main Business Overview
13.5.5 Orion Latest Developments
13.6 Teva Pharmaceutical
13.6.1 Teva Pharmaceutical Company Information
13.6.2 Teva Pharmaceutical Anti-androgen Drugs Product Portfolios and Specifications
13.6.3 Teva Pharmaceutical Anti-androgen Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Teva Pharmaceutical Main Business Overview
13.6.5 Teva Pharmaceutical Latest Developments
13.7 Sun Pharmaceutical
13.7.1 Sun Pharmaceutical Company Information
13.7.2 Sun Pharmaceutical Anti-androgen Drugs Product Portfolios and Specifications
13.7.3 Sun Pharmaceutical Anti-androgen Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Sun Pharmaceutical Main Business Overview
13.7.5 Sun Pharmaceutical Latest Developments
13.8 Dr. Reddy's Laboratories
13.8.1 Dr. Reddy's Laboratories Company Information
13.8.2 Dr. Reddy's Laboratories Anti-androgen Drugs Product Portfolios and Specifications
13.8.3 Dr. Reddy's Laboratories Anti-androgen Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Dr. Reddy's Laboratories Main Business Overview
13.8.5 Dr. Reddy's Laboratories Latest Developments
13.9 Cipla
13.9.1 Cipla Company Information
13.9.2 Cipla Anti-androgen Drugs Product Portfolios and Specifications
13.9.3 Cipla Anti-androgen Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Cipla Main Business Overview
13.9.5 Cipla Latest Developments
13.10 Hengrui Pharmaceuticals
13.10.1 Hengrui Pharmaceuticals Company Information
13.10.2 Hengrui Pharmaceuticals Anti-androgen Drugs Product Portfolios and Specifications
13.10.3 Hengrui Pharmaceuticals Anti-androgen Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Hengrui Pharmaceuticals Main Business Overview
13.10.5 Hengrui Pharmaceuticals Latest Developments
13.11 Lonza Group
13.11.1 Lonza Group Company Information
13.11.2 Lonza Group Anti-androgen Drugs Product Portfolios and Specifications
13.11.3 Lonza Group Anti-androgen Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Lonza Group Main Business Overview
13.11.5 Lonza Group Latest Developments
13.12 WuXi AppTec
13.12.1 WuXi AppTec Company Information
13.12.2 WuXi AppTec Anti-androgen Drugs Product Portfolios and Specifications
13.12.3 WuXi AppTec Anti-androgen Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 WuXi AppTec Main Business Overview
13.12.5 WuXi AppTec Latest Developments
13.13 Asymchem Laboratories
13.13.1 Asymchem Laboratories Company Information
13.13.2 Asymchem Laboratories Anti-androgen Drugs Product Portfolios and Specifications
13.13.3 Asymchem Laboratories Anti-androgen Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Asymchem Laboratories Main Business Overview
13.13.5 Asymchem Laboratories Latest Developments
13.14 Catalent
13.14.1 Catalent Company Information
13.14.2 Catalent Anti-androgen Drugs Product Portfolios and Specifications
13.14.3 Catalent Anti-androgen Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Catalent Main Business Overview
13.14.5 Catalent Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-androgen Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Anti-androgen Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Anti-androgen Drugs by Country/Region, 2021, 2025 & 2032
2.2 Anti-androgen Drugs Segment by Type
2.2.1 NSARIs
2.2.2 SARIs
2.2.3 ASIs
2.2.4 Anti-androgen Drugs Sales by Type
2.2.4.1 Global Anti-androgen Drugs Sales Market Share by Type (2021-2026)
2.2.4.2 Global Anti-androgen Drugs Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Anti-androgen Drugs Sale Price by Type (2021-2026)
2.3 Anti-androgen Drugs Segment by Generation
2.3.1 1st Gen
2.3.2 2nd Gen
2.3.3 Anti-androgen Drugs Sales by Generation
2.3.3.1 Global Anti-androgen Drugs Sales Market Share by Generation (2021-2026)
2.3.3.2 Global Anti-androgen Drugs Revenue and Market Share by Generation (2021-2026)
2.3.3.3 Global Anti-androgen Drugs Sale Price by Generation (2021-2026)
2.4 Anti-androgen Drugs Segment by Application
2.4.1 nmCRPC
2.4.2 mCRPC
2.4.3 mHSPC
2.4.4 Special Endocrine / Female
2.4.5 Anti-androgen Drugs Sales by Application
2.4.5.1 Global Anti-androgen Drugs Sale Market Share by Application (2021-2026)
2.4.5.2 Global Anti-androgen Drugs Revenue and Market Share by Application (2021-2026)
2.4.5.3 Global Anti-androgen Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Anti-androgen Drugs Breakdown Data by Company
3.1.1 Global Anti-androgen Drugs Annual Sales by Company (2021-2026)
3.1.2 Global Anti-androgen Drugs Sales Market Share by Company (2021-2026)
3.2 Global Anti-androgen Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global Anti-androgen Drugs Revenue by Company (2021-2026)
3.2.2 Global Anti-androgen Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Anti-androgen Drugs Sale Price by Company
3.4 Key Manufacturers Anti-androgen Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-androgen Drugs Product Location Distribution
3.4.2 Players Anti-androgen Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTI-ANDROGEN DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Anti-androgen Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global Anti-androgen Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Anti-androgen Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Anti-androgen Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global Anti-androgen Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global Anti-androgen Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Anti-androgen Drugs Sales Growth
4.4 APAC Anti-androgen Drugs Sales Growth
4.5 Europe Anti-androgen Drugs Sales Growth
4.6 Middle East & Africa Anti-androgen Drugs Sales Growth
5 AMERICAS
5.1 Americas Anti-androgen Drugs Sales by Country
5.1.1 Americas Anti-androgen Drugs Sales by Country (2021-2026)
5.1.2 Americas Anti-androgen Drugs Revenue by Country (2021-2026)
5.2 Americas Anti-androgen Drugs Sales by Type (2021-2026)
5.3 Americas Anti-androgen Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-androgen Drugs Sales by Region
6.1.1 APAC Anti-androgen Drugs Sales by Region (2021-2026)
6.1.2 APAC Anti-androgen Drugs Revenue by Region (2021-2026)
6.2 APAC Anti-androgen Drugs Sales by Type (2021-2026)
6.3 APAC Anti-androgen Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Anti-androgen Drugs by Country
7.1.1 Europe Anti-androgen Drugs Sales by Country (2021-2026)
7.1.2 Europe Anti-androgen Drugs Revenue by Country (2021-2026)
7.2 Europe Anti-androgen Drugs Sales by Type (2021-2026)
7.3 Europe Anti-androgen Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-androgen Drugs by Country
8.1.1 Middle East & Africa Anti-androgen Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa Anti-androgen Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Anti-androgen Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Anti-androgen Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-androgen Drugs
10.3 Manufacturing Process Analysis of Anti-androgen Drugs
10.4 Industry Chain Structure of Anti-androgen Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-androgen Drugs Distributors
11.3 Anti-androgen Drugs Customer
12 WORLD FORECAST REVIEW FOR ANTI-ANDROGEN DRUGS BY GEOGRAPHIC REGION
12.1 Global Anti-androgen Drugs Market Size Forecast by Region
12.1.1 Global Anti-androgen Drugs Forecast by Region (2027-2032)
12.1.2 Global Anti-androgen Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Anti-androgen Drugs Forecast by Type (2027-2032)
12.7 Global Anti-androgen Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Astellas
13.1.1 Astellas Company Information
13.1.2 Astellas Anti-androgen Drugs Product Portfolios and Specifications
13.1.3 Astellas Anti-androgen Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Astellas Main Business Overview
13.1.5 Astellas Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Anti-androgen Drugs Product Portfolios and Specifications
13.2.3 Pfizer Anti-androgen Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Information
13.3.2 Johnson & Johnson Anti-androgen Drugs Product Portfolios and Specifications
13.3.3 Johnson & Johnson Anti-androgen Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Johnson & Johnson Main Business Overview
13.3.5 Johnson & Johnson Latest Developments
13.4 Bayer AG
13.4.1 Bayer AG Company Information
13.4.2 Bayer AG Anti-androgen Drugs Product Portfolios and Specifications
13.4.3 Bayer AG Anti-androgen Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Bayer AG Main Business Overview
13.4.5 Bayer AG Latest Developments
13.5 Orion
13.5.1 Orion Company Information
13.5.2 Orion Anti-androgen Drugs Product Portfolios and Specifications
13.5.3 Orion Anti-androgen Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Orion Main Business Overview
13.5.5 Orion Latest Developments
13.6 Teva Pharmaceutical
13.6.1 Teva Pharmaceutical Company Information
13.6.2 Teva Pharmaceutical Anti-androgen Drugs Product Portfolios and Specifications
13.6.3 Teva Pharmaceutical Anti-androgen Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Teva Pharmaceutical Main Business Overview
13.6.5 Teva Pharmaceutical Latest Developments
13.7 Sun Pharmaceutical
13.7.1 Sun Pharmaceutical Company Information
13.7.2 Sun Pharmaceutical Anti-androgen Drugs Product Portfolios and Specifications
13.7.3 Sun Pharmaceutical Anti-androgen Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Sun Pharmaceutical Main Business Overview
13.7.5 Sun Pharmaceutical Latest Developments
13.8 Dr. Reddy's Laboratories
13.8.1 Dr. Reddy's Laboratories Company Information
13.8.2 Dr. Reddy's Laboratories Anti-androgen Drugs Product Portfolios and Specifications
13.8.3 Dr. Reddy's Laboratories Anti-androgen Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Dr. Reddy's Laboratories Main Business Overview
13.8.5 Dr. Reddy's Laboratories Latest Developments
13.9 Cipla
13.9.1 Cipla Company Information
13.9.2 Cipla Anti-androgen Drugs Product Portfolios and Specifications
13.9.3 Cipla Anti-androgen Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Cipla Main Business Overview
13.9.5 Cipla Latest Developments
13.10 Hengrui Pharmaceuticals
13.10.1 Hengrui Pharmaceuticals Company Information
13.10.2 Hengrui Pharmaceuticals Anti-androgen Drugs Product Portfolios and Specifications
13.10.3 Hengrui Pharmaceuticals Anti-androgen Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Hengrui Pharmaceuticals Main Business Overview
13.10.5 Hengrui Pharmaceuticals Latest Developments
13.11 Lonza Group
13.11.1 Lonza Group Company Information
13.11.2 Lonza Group Anti-androgen Drugs Product Portfolios and Specifications
13.11.3 Lonza Group Anti-androgen Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Lonza Group Main Business Overview
13.11.5 Lonza Group Latest Developments
13.12 WuXi AppTec
13.12.1 WuXi AppTec Company Information
13.12.2 WuXi AppTec Anti-androgen Drugs Product Portfolios and Specifications
13.12.3 WuXi AppTec Anti-androgen Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 WuXi AppTec Main Business Overview
13.12.5 WuXi AppTec Latest Developments
13.13 Asymchem Laboratories
13.13.1 Asymchem Laboratories Company Information
13.13.2 Asymchem Laboratories Anti-androgen Drugs Product Portfolios and Specifications
13.13.3 Asymchem Laboratories Anti-androgen Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Asymchem Laboratories Main Business Overview
13.13.5 Asymchem Laboratories Latest Developments
13.14 Catalent
13.14.1 Catalent Company Information
13.14.2 Catalent Anti-androgen Drugs Product Portfolios and Specifications
13.14.3 Catalent Anti-androgen Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Catalent Main Business Overview
13.14.5 Catalent Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Anti-androgen Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Anti-androgen Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of NSARIs
Table 4. Major Players of SARIs
Table 5. Major Players of ASIs
Table 6. Global Anti-androgen Drugs Sales by Type (2021-2026) & (K Dose)
Table 7. Global Anti-androgen Drugs Sales Market Share by Type (2021-2026)
Table 8. Global Anti-androgen Drugs Revenue by Type (2021-2026) & ($ million)
Table 9. Global Anti-androgen Drugs Revenue Market Share by Type (2021-2026)
Table 10. Global Anti-androgen Drugs Sale Price by Type (2021-2026) & (US$/Dose)
Table 11. Major Players of 1st Gen
Table 12. Major Players of 2nd Gen
Table 13. Global Anti-androgen Drugs Sales by Generation (2021-2026) & (K Dose)
Table 14. Global Anti-androgen Drugs Sales Market Share by Generation (2021-2026)
Table 15. Global Anti-androgen Drugs Revenue by Generation (2021-2026) & ($ million)
Table 16. Global Anti-androgen Drugs Revenue Market Share by Generation (2021-2026)
Table 17. Global Anti-androgen Drugs Sale Price by Generation (2021-2026) & (US$/Dose)
Table 18. Global Anti-androgen Drugs Sale by Application (2021-2026) & (K Dose)
Table 19. Global Anti-androgen Drugs Sale Market Share by Application (2021-2026)
Table 20. Global Anti-androgen Drugs Revenue by Application (2021-2026) & ($ million)
Table 21. Global Anti-androgen Drugs Revenue Market Share by Application (2021-2026)
Table 22. Global Anti-androgen Drugs Sale Price by Application (2021-2026) & (US$/Dose)
Table 23. Global Anti-androgen Drugs Sales by Company (2021-2026) & (K Dose)
Table 24. Global Anti-androgen Drugs Sales Market Share by Company (2021-2026)
Table 25. Global Anti-androgen Drugs Revenue by Company (2021-2026) & ($ millions)
Table 26. Global Anti-androgen Drugs Revenue Market Share by Company (2021-2026)
Table 27. Global Anti-androgen Drugs Sale Price by Company (2021-2026) & (US$/Dose)
Table 28. Key Manufacturers Anti-androgen Drugs Producing Area Distribution and Sales Area
Table 29. Players Anti-androgen Drugs Products Offered
Table 30. Anti-androgen Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 31. New Products and Potential Entrants
Table 32. Market M&A Activity & Strategy
Table 33. Global Anti-androgen Drugs Sales by Geographic Region (2021-2026) & (K Dose)
Table 34. Global Anti-androgen Drugs Sales Market Share Geographic Region (2021-2026)
Table 35. Global Anti-androgen Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 36. Global Anti-androgen Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 37. Global Anti-androgen Drugs Sales by Country/Region (2021-2026) & (K Dose)
Table 38. Global Anti-androgen Drugs Sales Market Share by Country/Region (2021-2026)
Table 39. Global Anti-androgen Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 40. Global Anti-androgen Drugs Revenue Market Share by Country/Region (2021-2026)
Table 41. Americas Anti-androgen Drugs Sales by Country (2021-2026) & (K Dose)
Table 42. Americas Anti-androgen Drugs Sales Market Share by Country (2021-2026)
Table 43. Americas Anti-androgen Drugs Revenue by Country (2021-2026) & ($ millions)
Table 44. Americas Anti-androgen Drugs Sales by Type (2021-2026) & (K Dose)
Table 45. Americas Anti-androgen Drugs Sales by Application (2021-2026) & (K Dose)
Table 46. APAC Anti-androgen Drugs Sales by Region (2021-2026) & (K Dose)
Table 47. APAC Anti-androgen Drugs Sales Market Share by Region (2021-2026)
Table 48. APAC Anti-androgen Drugs Revenue by Region (2021-2026) & ($ millions)
Table 49. APAC Anti-androgen Drugs Sales by Type (2021-2026) & (K Dose)
Table 50. APAC Anti-androgen Drugs Sales by Application (2021-2026) & (K Dose)
Table 51. Europe Anti-androgen Drugs Sales by Country (2021-2026) & (K Dose)
Table 52. Europe Anti-androgen Drugs Revenue by Country (2021-2026) & ($ millions)
Table 53. Europe Anti-androgen Drugs Sales by Type (2021-2026) & (K Dose)
Table 54. Europe Anti-androgen Drugs Sales by Application (2021-2026) & (K Dose)
Table 55. Middle East & Africa Anti-androgen Drugs Sales by Country (2021-2026) & (K Dose)
Table 56. Middle East & Africa Anti-androgen Drugs Revenue Market Share by Country (2021-2026)
Table 57. Middle East & Africa Anti-androgen Drugs Sales by Type (2021-2026) & (K Dose)
Table 58. Middle East & Africa Anti-androgen Drugs Sales by Application (2021-2026) & (K Dose)
Table 59. Key Market Drivers & Growth Opportunities of Anti-androgen Drugs
Table 60. Key Market Challenges & Risks of Anti-androgen Drugs
Table 61. Key Industry Trends of Anti-androgen Drugs
Table 62. Anti-androgen Drugs Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Anti-androgen Drugs Distributors List
Table 65. Anti-androgen Drugs Customer List
Table 66. Global Anti-androgen Drugs Sales Forecast by Region (2027-2032) & (K Dose)
Table 67. Global Anti-androgen Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 68. Americas Anti-androgen Drugs Sales Forecast by Country (2027-2032) & (K Dose)
Table 69. Americas Anti-androgen Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. APAC Anti-androgen Drugs Sales Forecast by Region (2027-2032) & (K Dose)
Table 71. APAC Anti-androgen Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 72. Europe Anti-androgen Drugs Sales Forecast by Country (2027-2032) & (K Dose)
Table 73. Europe Anti-androgen Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 74. Middle East & Africa Anti-androgen Drugs Sales Forecast by Country (2027-2032) & (K Dose)
Table 75. Middle East & Africa Anti-androgen Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 76. Global Anti-androgen Drugs Sales Forecast by Type (2027-2032) & (K Dose)
Table 77. Global Anti-androgen Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 78. Global Anti-androgen Drugs Sales Forecast by Application (2027-2032) & (K Dose)
Table 79. Global Anti-androgen Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 80. Astellas Basic Information, Anti-androgen Drugs Manufacturing Base, Sales Area and Its Competitors
Table 81. Astellas Anti-androgen Drugs Product Portfolios and Specifications
Table 82. Astellas Anti-androgen Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 83. Astellas Main Business
Table 84. Astellas Latest Developments
Table 85. Pfizer Basic Information, Anti-androgen Drugs Manufacturing Base, Sales Area and Its Competitors
Table 86. Pfizer Anti-androgen Drugs Product Portfolios and Specifications
Table 87. Pfizer Anti-androgen Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 88. Pfizer Main Business
Table 89. Pfizer Latest Developments
Table 90. Johnson & Johnson Basic Information, Anti-androgen Drugs Manufacturing Base, Sales Area and Its Competitors
Table 91. Johnson & Johnson Anti-androgen Drugs Product Portfolios and Specifications
Table 92. Johnson & Johnson Anti-androgen Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 93. Johnson & Johnson Main Business
Table 94. Johnson & Johnson Latest Developments
Table 95. Bayer AG Basic Information, Anti-androgen Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. Bayer AG Anti-androgen Drugs Product Portfolios and Specifications
Table 97. Bayer AG Anti-androgen Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 98. Bayer AG Main Business
Table 99. Bayer AG Latest Developments
Table 100. Orion Basic Information, Anti-androgen Drugs Manufacturing Base, Sales Area and Its Competitors
Table 101. Orion Anti-androgen Drugs Product Portfolios and Specifications
Table 102. Orion Anti-androgen Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 103. Orion Main Business
Table 104. Orion Latest Developments
Table 105. Teva Pharmaceutical Basic Information, Anti-androgen Drugs Manufacturing Base, Sales Area and Its Competitors
Table 106. Teva Pharmaceutical Anti-androgen Drugs Product Portfolios and Specifications
Table 107. Teva Pharmaceutical Anti-androgen Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 108. Teva Pharmaceutical Main Business
Table 109. Teva Pharmaceutical Latest Developments
Table 110. Sun Pharmaceutical Basic Information, Anti-androgen Drugs Manufacturing Base, Sales Area and Its Competitors
Table 111. Sun Pharmaceutical Anti-androgen Drugs Product Portfolios and Specifications
Table 112. Sun Pharmaceutical Anti-androgen Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 113. Sun Pharmaceutical Main Business
Table 114. Sun Pharmaceutical Latest Developments
Table 115. Dr. Reddy's Laboratories Basic Information, Anti-androgen Drugs Manufacturing Base, Sales Area and Its Competitors
Table 116. Dr. Reddy's Laboratories Anti-androgen Drugs Product Portfolios and Specifications
Table 117. Dr. Reddy's Laboratories Anti-androgen Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 118. Dr. Reddy's Laboratories Main Business
Table 119. Dr. Reddy's Laboratories Latest Developments
Table 120. Cipla Basic Information, Anti-androgen Drugs Manufacturing Base, Sales Area and Its Competitors
Table 121. Cipla Anti-androgen Drugs Product Portfolios and Specifications
Table 122. Cipla Anti-androgen Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 123. Cipla Main Business
Table 124. Cipla Latest Developments
Table 125. Hengrui Pharmaceuticals Basic Information, Anti-androgen Drugs Manufacturing Base, Sales Area and Its Competitors
Table 126. Hengrui Pharmaceuticals Anti-androgen Drugs Product Portfolios and Specifications
Table 127. Hengrui Pharmaceuticals Anti-androgen Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 128. Hengrui Pharmaceuticals Main Business
Table 129. Hengrui Pharmaceuticals Latest Developments
Table 130. Lonza Group Basic Information, Anti-androgen Drugs Manufacturing Base, Sales Area and Its Competitors
Table 131. Lonza Group Anti-androgen Drugs Product Portfolios and Specifications
Table 132. Lonza Group Anti-androgen Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 133. Lonza Group Main Business
Table 134. Lonza Group Latest Developments
Table 135. WuXi AppTec Basic Information, Anti-androgen Drugs Manufacturing Base, Sales Area and Its Competitors
Table 136. WuXi AppTec Anti-androgen Drugs Product Portfolios and Specifications
Table 137. WuXi AppTec Anti-androgen Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 138. WuXi AppTec Main Business
Table 139. WuXi AppTec Latest Developments
Table 140. Asymchem Laboratories Basic Information, Anti-androgen Drugs Manufacturing Base, Sales Area and Its Competitors
Table 141. Asymchem Laboratories Anti-androgen Drugs Product Portfolios and Specifications
Table 142. Asymchem Laboratories Anti-androgen Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 143. Asymchem Laboratories Main Business
Table 144. Asymchem Laboratories Latest Developments
Table 145. Catalent Basic Information, Anti-androgen Drugs Manufacturing Base, Sales Area and Its Competitors
Table 146. Catalent Anti-androgen Drugs Product Portfolios and Specifications
Table 147. Catalent Anti-androgen Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 148. Catalent Main Business
Table 149. Catalent Latest Developments
Table 1. Anti-androgen Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Anti-androgen Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of NSARIs
Table 4. Major Players of SARIs
Table 5. Major Players of ASIs
Table 6. Global Anti-androgen Drugs Sales by Type (2021-2026) & (K Dose)
Table 7. Global Anti-androgen Drugs Sales Market Share by Type (2021-2026)
Table 8. Global Anti-androgen Drugs Revenue by Type (2021-2026) & ($ million)
Table 9. Global Anti-androgen Drugs Revenue Market Share by Type (2021-2026)
Table 10. Global Anti-androgen Drugs Sale Price by Type (2021-2026) & (US$/Dose)
Table 11. Major Players of 1st Gen
Table 12. Major Players of 2nd Gen
Table 13. Global Anti-androgen Drugs Sales by Generation (2021-2026) & (K Dose)
Table 14. Global Anti-androgen Drugs Sales Market Share by Generation (2021-2026)
Table 15. Global Anti-androgen Drugs Revenue by Generation (2021-2026) & ($ million)
Table 16. Global Anti-androgen Drugs Revenue Market Share by Generation (2021-2026)
Table 17. Global Anti-androgen Drugs Sale Price by Generation (2021-2026) & (US$/Dose)
Table 18. Global Anti-androgen Drugs Sale by Application (2021-2026) & (K Dose)
Table 19. Global Anti-androgen Drugs Sale Market Share by Application (2021-2026)
Table 20. Global Anti-androgen Drugs Revenue by Application (2021-2026) & ($ million)
Table 21. Global Anti-androgen Drugs Revenue Market Share by Application (2021-2026)
Table 22. Global Anti-androgen Drugs Sale Price by Application (2021-2026) & (US$/Dose)
Table 23. Global Anti-androgen Drugs Sales by Company (2021-2026) & (K Dose)
Table 24. Global Anti-androgen Drugs Sales Market Share by Company (2021-2026)
Table 25. Global Anti-androgen Drugs Revenue by Company (2021-2026) & ($ millions)
Table 26. Global Anti-androgen Drugs Revenue Market Share by Company (2021-2026)
Table 27. Global Anti-androgen Drugs Sale Price by Company (2021-2026) & (US$/Dose)
Table 28. Key Manufacturers Anti-androgen Drugs Producing Area Distribution and Sales Area
Table 29. Players Anti-androgen Drugs Products Offered
Table 30. Anti-androgen Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 31. New Products and Potential Entrants
Table 32. Market M&A Activity & Strategy
Table 33. Global Anti-androgen Drugs Sales by Geographic Region (2021-2026) & (K Dose)
Table 34. Global Anti-androgen Drugs Sales Market Share Geographic Region (2021-2026)
Table 35. Global Anti-androgen Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 36. Global Anti-androgen Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 37. Global Anti-androgen Drugs Sales by Country/Region (2021-2026) & (K Dose)
Table 38. Global Anti-androgen Drugs Sales Market Share by Country/Region (2021-2026)
Table 39. Global Anti-androgen Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 40. Global Anti-androgen Drugs Revenue Market Share by Country/Region (2021-2026)
Table 41. Americas Anti-androgen Drugs Sales by Country (2021-2026) & (K Dose)
Table 42. Americas Anti-androgen Drugs Sales Market Share by Country (2021-2026)
Table 43. Americas Anti-androgen Drugs Revenue by Country (2021-2026) & ($ millions)
Table 44. Americas Anti-androgen Drugs Sales by Type (2021-2026) & (K Dose)
Table 45. Americas Anti-androgen Drugs Sales by Application (2021-2026) & (K Dose)
Table 46. APAC Anti-androgen Drugs Sales by Region (2021-2026) & (K Dose)
Table 47. APAC Anti-androgen Drugs Sales Market Share by Region (2021-2026)
Table 48. APAC Anti-androgen Drugs Revenue by Region (2021-2026) & ($ millions)
Table 49. APAC Anti-androgen Drugs Sales by Type (2021-2026) & (K Dose)
Table 50. APAC Anti-androgen Drugs Sales by Application (2021-2026) & (K Dose)
Table 51. Europe Anti-androgen Drugs Sales by Country (2021-2026) & (K Dose)
Table 52. Europe Anti-androgen Drugs Revenue by Country (2021-2026) & ($ millions)
Table 53. Europe Anti-androgen Drugs Sales by Type (2021-2026) & (K Dose)
Table 54. Europe Anti-androgen Drugs Sales by Application (2021-2026) & (K Dose)
Table 55. Middle East & Africa Anti-androgen Drugs Sales by Country (2021-2026) & (K Dose)
Table 56. Middle East & Africa Anti-androgen Drugs Revenue Market Share by Country (2021-2026)
Table 57. Middle East & Africa Anti-androgen Drugs Sales by Type (2021-2026) & (K Dose)
Table 58. Middle East & Africa Anti-androgen Drugs Sales by Application (2021-2026) & (K Dose)
Table 59. Key Market Drivers & Growth Opportunities of Anti-androgen Drugs
Table 60. Key Market Challenges & Risks of Anti-androgen Drugs
Table 61. Key Industry Trends of Anti-androgen Drugs
Table 62. Anti-androgen Drugs Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Anti-androgen Drugs Distributors List
Table 65. Anti-androgen Drugs Customer List
Table 66. Global Anti-androgen Drugs Sales Forecast by Region (2027-2032) & (K Dose)
Table 67. Global Anti-androgen Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 68. Americas Anti-androgen Drugs Sales Forecast by Country (2027-2032) & (K Dose)
Table 69. Americas Anti-androgen Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. APAC Anti-androgen Drugs Sales Forecast by Region (2027-2032) & (K Dose)
Table 71. APAC Anti-androgen Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 72. Europe Anti-androgen Drugs Sales Forecast by Country (2027-2032) & (K Dose)
Table 73. Europe Anti-androgen Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 74. Middle East & Africa Anti-androgen Drugs Sales Forecast by Country (2027-2032) & (K Dose)
Table 75. Middle East & Africa Anti-androgen Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 76. Global Anti-androgen Drugs Sales Forecast by Type (2027-2032) & (K Dose)
Table 77. Global Anti-androgen Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 78. Global Anti-androgen Drugs Sales Forecast by Application (2027-2032) & (K Dose)
Table 79. Global Anti-androgen Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 80. Astellas Basic Information, Anti-androgen Drugs Manufacturing Base, Sales Area and Its Competitors
Table 81. Astellas Anti-androgen Drugs Product Portfolios and Specifications
Table 82. Astellas Anti-androgen Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 83. Astellas Main Business
Table 84. Astellas Latest Developments
Table 85. Pfizer Basic Information, Anti-androgen Drugs Manufacturing Base, Sales Area and Its Competitors
Table 86. Pfizer Anti-androgen Drugs Product Portfolios and Specifications
Table 87. Pfizer Anti-androgen Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 88. Pfizer Main Business
Table 89. Pfizer Latest Developments
Table 90. Johnson & Johnson Basic Information, Anti-androgen Drugs Manufacturing Base, Sales Area and Its Competitors
Table 91. Johnson & Johnson Anti-androgen Drugs Product Portfolios and Specifications
Table 92. Johnson & Johnson Anti-androgen Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 93. Johnson & Johnson Main Business
Table 94. Johnson & Johnson Latest Developments
Table 95. Bayer AG Basic Information, Anti-androgen Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. Bayer AG Anti-androgen Drugs Product Portfolios and Specifications
Table 97. Bayer AG Anti-androgen Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 98. Bayer AG Main Business
Table 99. Bayer AG Latest Developments
Table 100. Orion Basic Information, Anti-androgen Drugs Manufacturing Base, Sales Area and Its Competitors
Table 101. Orion Anti-androgen Drugs Product Portfolios and Specifications
Table 102. Orion Anti-androgen Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 103. Orion Main Business
Table 104. Orion Latest Developments
Table 105. Teva Pharmaceutical Basic Information, Anti-androgen Drugs Manufacturing Base, Sales Area and Its Competitors
Table 106. Teva Pharmaceutical Anti-androgen Drugs Product Portfolios and Specifications
Table 107. Teva Pharmaceutical Anti-androgen Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 108. Teva Pharmaceutical Main Business
Table 109. Teva Pharmaceutical Latest Developments
Table 110. Sun Pharmaceutical Basic Information, Anti-androgen Drugs Manufacturing Base, Sales Area and Its Competitors
Table 111. Sun Pharmaceutical Anti-androgen Drugs Product Portfolios and Specifications
Table 112. Sun Pharmaceutical Anti-androgen Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 113. Sun Pharmaceutical Main Business
Table 114. Sun Pharmaceutical Latest Developments
Table 115. Dr. Reddy's Laboratories Basic Information, Anti-androgen Drugs Manufacturing Base, Sales Area and Its Competitors
Table 116. Dr. Reddy's Laboratories Anti-androgen Drugs Product Portfolios and Specifications
Table 117. Dr. Reddy's Laboratories Anti-androgen Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 118. Dr. Reddy's Laboratories Main Business
Table 119. Dr. Reddy's Laboratories Latest Developments
Table 120. Cipla Basic Information, Anti-androgen Drugs Manufacturing Base, Sales Area and Its Competitors
Table 121. Cipla Anti-androgen Drugs Product Portfolios and Specifications
Table 122. Cipla Anti-androgen Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 123. Cipla Main Business
Table 124. Cipla Latest Developments
Table 125. Hengrui Pharmaceuticals Basic Information, Anti-androgen Drugs Manufacturing Base, Sales Area and Its Competitors
Table 126. Hengrui Pharmaceuticals Anti-androgen Drugs Product Portfolios and Specifications
Table 127. Hengrui Pharmaceuticals Anti-androgen Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 128. Hengrui Pharmaceuticals Main Business
Table 129. Hengrui Pharmaceuticals Latest Developments
Table 130. Lonza Group Basic Information, Anti-androgen Drugs Manufacturing Base, Sales Area and Its Competitors
Table 131. Lonza Group Anti-androgen Drugs Product Portfolios and Specifications
Table 132. Lonza Group Anti-androgen Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 133. Lonza Group Main Business
Table 134. Lonza Group Latest Developments
Table 135. WuXi AppTec Basic Information, Anti-androgen Drugs Manufacturing Base, Sales Area and Its Competitors
Table 136. WuXi AppTec Anti-androgen Drugs Product Portfolios and Specifications
Table 137. WuXi AppTec Anti-androgen Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 138. WuXi AppTec Main Business
Table 139. WuXi AppTec Latest Developments
Table 140. Asymchem Laboratories Basic Information, Anti-androgen Drugs Manufacturing Base, Sales Area and Its Competitors
Table 141. Asymchem Laboratories Anti-androgen Drugs Product Portfolios and Specifications
Table 142. Asymchem Laboratories Anti-androgen Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 143. Asymchem Laboratories Main Business
Table 144. Asymchem Laboratories Latest Developments
Table 145. Catalent Basic Information, Anti-androgen Drugs Manufacturing Base, Sales Area and Its Competitors
Table 146. Catalent Anti-androgen Drugs Product Portfolios and Specifications
Table 147. Catalent Anti-androgen Drugs Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 148. Catalent Main Business
Table 149. Catalent Latest Developments
LIST OF FIGURES
Figure 1. Picture of Anti-androgen Drugs
Figure 2. Anti-androgen Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-androgen Drugs Sales Growth Rate 2021-2032 (K Dose)
Figure 7. Global Anti-androgen Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Anti-androgen Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Anti-androgen Drugs Sales Market Share by Country/Region (2025)
Figure 10. Anti-androgen Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of NSARIs
Figure 12. Product Picture of SARIs
Figure 13. Product Picture of ASIs
Figure 14. Global Anti-androgen Drugs Sales Market Share by Type in 2026
Figure 15. Global Anti-androgen Drugs Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of 1st Gen
Figure 17. Product Picture of 2nd Gen
Figure 18. Global Anti-androgen Drugs Sales Market Share by Generation in 2026
Figure 19. Global Anti-androgen Drugs Revenue Market Share by Generation (2021-2026)
Figure 20. Anti-androgen Drugs Consumed in nmCRPC
Figure 21. Global Anti-androgen Drugs Market: nmCRPC (2021-2026) & (K Dose)
Figure 22. Anti-androgen Drugs Consumed in mCRPC
Figure 23. Global Anti-androgen Drugs Market: mCRPC (2021-2026) & (K Dose)
Figure 24. Anti-androgen Drugs Consumed in mHSPC
Figure 25. Global Anti-androgen Drugs Market: mHSPC (2021-2026) & (K Dose)
Figure 26. Anti-androgen Drugs Consumed in Special Endocrine / Female
Figure 27. Global Anti-androgen Drugs Market: Special Endocrine / Female (2021-2026) & (K Dose)
Figure 28. Global Anti-androgen Drugs Sale Market Share by Application (2025)
Figure 29. Global Anti-androgen Drugs Revenue Market Share by Application in 2025
Figure 30. Anti-androgen Drugs Sales by Company in 2025 (K Dose)
Figure 31. Global Anti-androgen Drugs Sales Market Share by Company in 2025
Figure 32. Anti-androgen Drugs Revenue by Company in 2025 ($ millions)
Figure 33. Global Anti-androgen Drugs Revenue Market Share by Company in 2025
Figure 34. Global Anti-androgen Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 35. Global Anti-androgen Drugs Revenue Market Share by Geographic Region in 2025
Figure 36. Americas Anti-androgen Drugs Sales 2021-2026 (K Dose)
Figure 37. Americas Anti-androgen Drugs Revenue 2021-2026 ($ millions)
Figure 38. APAC Anti-androgen Drugs Sales 2021-2026 (K Dose)
Figure 39. APAC Anti-androgen Drugs Revenue 2021-2026 ($ millions)
Figure 40. Europe Anti-androgen Drugs Sales 2021-2026 (K Dose)
Figure 41. Europe Anti-androgen Drugs Revenue 2021-2026 ($ millions)
Figure 42. Middle East & Africa Anti-androgen Drugs Sales 2021-2026 (K Dose)
Figure 43. Middle East & Africa Anti-androgen Drugs Revenue 2021-2026 ($ millions)
Figure 44. Americas Anti-androgen Drugs Sales Market Share by Country in 2025
Figure 45. Americas Anti-androgen Drugs Revenue Market Share by Country (2021-2026)
Figure 46. Americas Anti-androgen Drugs Sales Market Share by Type (2021-2026)
Figure 47. Americas Anti-androgen Drugs Sales Market Share by Application (2021-2026)
Figure 48. United States Anti-androgen Drugs Revenue Growth 2021-2026 ($ millions)
Figure 49. Canada Anti-androgen Drugs Revenue Growth 2021-2026 ($ millions)
Figure 50. Mexico Anti-androgen Drugs Revenue Growth 2021-2026 ($ millions)
Figure 51. Brazil Anti-androgen Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. APAC Anti-androgen Drugs Sales Market Share by Region in 2025
Figure 53. APAC Anti-androgen Drugs Revenue Market Share by Region (2021-2026)
Figure 54. APAC Anti-androgen Drugs Sales Market Share by Type (2021-2026)
Figure 55. APAC Anti-androgen Drugs Sales Market Share by Application (2021-2026)
Figure 56. China Anti-androgen Drugs Revenue Growth 2021-2026 ($ millions)
Figure 57. Japan Anti-androgen Drugs Revenue Growth 2021-2026 ($ millions)
Figure 58. South Korea Anti-androgen Drugs Revenue Growth 2021-2026 ($ millions)
Figure 59. Southeast Asia Anti-androgen Drugs Revenue Growth 2021-2026 ($ millions)
Figure 60. India Anti-androgen Drugs Revenue Growth 2021-2026 ($ millions)
Figure 61. Australia Anti-androgen Drugs Revenue Growth 2021-2026 ($ millions)
Figure 62. China Taiwan Anti-androgen Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. Europe Anti-androgen Drugs Sales Market Share by Country in 2025
Figure 64. Europe Anti-androgen Drugs Revenue Market Share by Country (2021-2026)
Figure 65. Europe Anti-androgen Drugs Sales Market Share by Type (2021-2026)
Figure 66. Europe Anti-androgen Drugs Sales Market Share by Application (2021-2026)
Figure 67. Germany Anti-androgen Drugs Revenue Growth 2021-2026 ($ millions)
Figure 68. France Anti-androgen Drugs Revenue Growth 2021-2026 ($ millions)
Figure 69. UK Anti-androgen Drugs Revenue Growth 2021-2026 ($ millions)
Figure 70. Italy Anti-androgen Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. Russia Anti-androgen Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. Middle East & Africa Anti-androgen Drugs Sales Market Share by Country (2021-2026)
Figure 73. Middle East & Africa Anti-androgen Drugs Sales Market Share by Type (2021-2026)
Figure 74. Middle East & Africa Anti-androgen Drugs Sales Market Share by Application (2021-2026)
Figure 75. Egypt Anti-androgen Drugs Revenue Growth 2021-2026 ($ millions)
Figure 76. South Africa Anti-androgen Drugs Revenue Growth 2021-2026 ($ millions)
Figure 77. Israel Anti-androgen Drugs Revenue Growth 2021-2026 ($ millions)
Figure 78. Turkey Anti-androgen Drugs Revenue Growth 2021-2026 ($ millions)
Figure 79. GCC Countries Anti-androgen Drugs Revenue Growth 2021-2026 ($ millions)
Figure 80. Manufacturing Cost Structure Analysis of Anti-androgen Drugs in 2026
Figure 81. Manufacturing Process Analysis of Anti-androgen Drugs
Figure 82. Industry Chain Structure of Anti-androgen Drugs
Figure 83. Channels of Distribution
Figure 84. Global Anti-androgen Drugs Sales Market Forecast by Region (2027-2032)
Figure 85. Global Anti-androgen Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 86. Global Anti-androgen Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 87. Global Anti-androgen Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 88. Global Anti-androgen Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 89. Global Anti-androgen Drugs Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Anti-androgen Drugs
Figure 2. Anti-androgen Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-androgen Drugs Sales Growth Rate 2021-2032 (K Dose)
Figure 7. Global Anti-androgen Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Anti-androgen Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Anti-androgen Drugs Sales Market Share by Country/Region (2025)
Figure 10. Anti-androgen Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of NSARIs
Figure 12. Product Picture of SARIs
Figure 13. Product Picture of ASIs
Figure 14. Global Anti-androgen Drugs Sales Market Share by Type in 2026
Figure 15. Global Anti-androgen Drugs Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of 1st Gen
Figure 17. Product Picture of 2nd Gen
Figure 18. Global Anti-androgen Drugs Sales Market Share by Generation in 2026
Figure 19. Global Anti-androgen Drugs Revenue Market Share by Generation (2021-2026)
Figure 20. Anti-androgen Drugs Consumed in nmCRPC
Figure 21. Global Anti-androgen Drugs Market: nmCRPC (2021-2026) & (K Dose)
Figure 22. Anti-androgen Drugs Consumed in mCRPC
Figure 23. Global Anti-androgen Drugs Market: mCRPC (2021-2026) & (K Dose)
Figure 24. Anti-androgen Drugs Consumed in mHSPC
Figure 25. Global Anti-androgen Drugs Market: mHSPC (2021-2026) & (K Dose)
Figure 26. Anti-androgen Drugs Consumed in Special Endocrine / Female
Figure 27. Global Anti-androgen Drugs Market: Special Endocrine / Female (2021-2026) & (K Dose)
Figure 28. Global Anti-androgen Drugs Sale Market Share by Application (2025)
Figure 29. Global Anti-androgen Drugs Revenue Market Share by Application in 2025
Figure 30. Anti-androgen Drugs Sales by Company in 2025 (K Dose)
Figure 31. Global Anti-androgen Drugs Sales Market Share by Company in 2025
Figure 32. Anti-androgen Drugs Revenue by Company in 2025 ($ millions)
Figure 33. Global Anti-androgen Drugs Revenue Market Share by Company in 2025
Figure 34. Global Anti-androgen Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 35. Global Anti-androgen Drugs Revenue Market Share by Geographic Region in 2025
Figure 36. Americas Anti-androgen Drugs Sales 2021-2026 (K Dose)
Figure 37. Americas Anti-androgen Drugs Revenue 2021-2026 ($ millions)
Figure 38. APAC Anti-androgen Drugs Sales 2021-2026 (K Dose)
Figure 39. APAC Anti-androgen Drugs Revenue 2021-2026 ($ millions)
Figure 40. Europe Anti-androgen Drugs Sales 2021-2026 (K Dose)
Figure 41. Europe Anti-androgen Drugs Revenue 2021-2026 ($ millions)
Figure 42. Middle East & Africa Anti-androgen Drugs Sales 2021-2026 (K Dose)
Figure 43. Middle East & Africa Anti-androgen Drugs Revenue 2021-2026 ($ millions)
Figure 44. Americas Anti-androgen Drugs Sales Market Share by Country in 2025
Figure 45. Americas Anti-androgen Drugs Revenue Market Share by Country (2021-2026)
Figure 46. Americas Anti-androgen Drugs Sales Market Share by Type (2021-2026)
Figure 47. Americas Anti-androgen Drugs Sales Market Share by Application (2021-2026)
Figure 48. United States Anti-androgen Drugs Revenue Growth 2021-2026 ($ millions)
Figure 49. Canada Anti-androgen Drugs Revenue Growth 2021-2026 ($ millions)
Figure 50. Mexico Anti-androgen Drugs Revenue Growth 2021-2026 ($ millions)
Figure 51. Brazil Anti-androgen Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. APAC Anti-androgen Drugs Sales Market Share by Region in 2025
Figure 53. APAC Anti-androgen Drugs Revenue Market Share by Region (2021-2026)
Figure 54. APAC Anti-androgen Drugs Sales Market Share by Type (2021-2026)
Figure 55. APAC Anti-androgen Drugs Sales Market Share by Application (2021-2026)
Figure 56. China Anti-androgen Drugs Revenue Growth 2021-2026 ($ millions)
Figure 57. Japan Anti-androgen Drugs Revenue Growth 2021-2026 ($ millions)
Figure 58. South Korea Anti-androgen Drugs Revenue Growth 2021-2026 ($ millions)
Figure 59. Southeast Asia Anti-androgen Drugs Revenue Growth 2021-2026 ($ millions)
Figure 60. India Anti-androgen Drugs Revenue Growth 2021-2026 ($ millions)
Figure 61. Australia Anti-androgen Drugs Revenue Growth 2021-2026 ($ millions)
Figure 62. China Taiwan Anti-androgen Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. Europe Anti-androgen Drugs Sales Market Share by Country in 2025
Figure 64. Europe Anti-androgen Drugs Revenue Market Share by Country (2021-2026)
Figure 65. Europe Anti-androgen Drugs Sales Market Share by Type (2021-2026)
Figure 66. Europe Anti-androgen Drugs Sales Market Share by Application (2021-2026)
Figure 67. Germany Anti-androgen Drugs Revenue Growth 2021-2026 ($ millions)
Figure 68. France Anti-androgen Drugs Revenue Growth 2021-2026 ($ millions)
Figure 69. UK Anti-androgen Drugs Revenue Growth 2021-2026 ($ millions)
Figure 70. Italy Anti-androgen Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. Russia Anti-androgen Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. Middle East & Africa Anti-androgen Drugs Sales Market Share by Country (2021-2026)
Figure 73. Middle East & Africa Anti-androgen Drugs Sales Market Share by Type (2021-2026)
Figure 74. Middle East & Africa Anti-androgen Drugs Sales Market Share by Application (2021-2026)
Figure 75. Egypt Anti-androgen Drugs Revenue Growth 2021-2026 ($ millions)
Figure 76. South Africa Anti-androgen Drugs Revenue Growth 2021-2026 ($ millions)
Figure 77. Israel Anti-androgen Drugs Revenue Growth 2021-2026 ($ millions)
Figure 78. Turkey Anti-androgen Drugs Revenue Growth 2021-2026 ($ millions)
Figure 79. GCC Countries Anti-androgen Drugs Revenue Growth 2021-2026 ($ millions)
Figure 80. Manufacturing Cost Structure Analysis of Anti-androgen Drugs in 2026
Figure 81. Manufacturing Process Analysis of Anti-androgen Drugs
Figure 82. Industry Chain Structure of Anti-androgen Drugs
Figure 83. Channels of Distribution
Figure 84. Global Anti-androgen Drugs Sales Market Forecast by Region (2027-2032)
Figure 85. Global Anti-androgen Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 86. Global Anti-androgen Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 87. Global Anti-androgen Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 88. Global Anti-androgen Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 89. Global Anti-androgen Drugs Revenue Market Share Forecast by Application (2027-2032)
